微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 43.38% | -19.01% | -13.41% | 86/139 | 51.97% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-12-31 | 50.1% | -3.86% | 1.19% | 74/139 | 51.43% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-09-30 | 49.51% | -8.59% | -4.82% | 75/139 | 51.66% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 52.02% | -6.65% | -2.89% | 71/139 | 51.8% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 53.56% | 0.47% | 2.79% | 65/139 | 51.48% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 52.11% | -9.21% | -3.78% | 72/139 | 52.35% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 54.16% | -3.98% | -2.8% | 66/139 | 53.23% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 55.72% | -0.79% | 4.51% | 65/139 | 53.35% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 53.31% | -5.6% | -7.12% | 66/139 | 53.36% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 57.4% | 34.92% | 1.76% | 60/139 | 53.18% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 56.41% | 29.21% | 0.43% | 64/139 | 54.03% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 56.16% | 35.67% | -0.55% | 64/139 | 53.47% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 56.47% | 49% | 32.74% | 62/139 | 53.71% | 正海生物 | 89.78% | 行业排名> |
| 2022-12-31 | 42.55% | -18.91% | -2.54% | 93/139 | 53.71% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 43.65% | -17.44% | 5.45% | 82/139 | 55.18% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 41.4% | -24.38% | 9.22% | 94/139 | 54.84% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 37.9% | -29.87% | -27.76% | 89/139 | 56.29% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 52.47% | -3.39% | -0.77% | 81/139 | 57.28% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 52.87% | -3.58% | -3.41% | 70/139 | 59.09% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 54.74% | 3.21% | 1.29% | 74/139 | 58.4% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 54.05% | 15.98% | -0.48% | 66/139 | 60.69% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 54.31% | -0.7% | -0.96% | 81/139 | 59.49% | 正海生物 | 92.23% | 行业排名> |
| 2020-09-30 | 54.84% | -0.13% | 3.39% | 59/139 | 61.43% | 正海生物 | 92.69% | 行业排名> |
| 2020-06-30 | 53.04% | -2.73% | 13.82% | 74/139 | 59.82% | 正海生物 | 92.61% | 行业排名> |
| 2020-03-31 | 46.6% | -4.84% | -14.79% | 52/139 | 58.15% | 正海生物 | 94.38% | 行业排名> |
| 2019-12-31 | 54.69% | 10.96% | -0.39% | 63/139 | 56.29% | 正海生物 | 93.12% | 行业排名> |
| 2019-09-30 | 54.91% | 12.14% | 0.7% | 33/139 | 55.04% | 正海生物 | 93.78% | 行业排名> |
| 2019-06-30 | 54.53% | 12.38% | 11.35% | 41/139 | 57.22% | 正海生物 | 93.09% | 行业排名> |
| 2019-03-31 | 48.97% | 9.54% | -0.65% | 27/139 | 51.81% | 正海生物 | 93.85% | 行业排名> |
| 2018-12-31 | 49.29% | -10.62% | 0.67% | 65/139 | 55.53% | 正海生物 | 93.08% | 行业排名> |
| 2018-09-30 | 48.97% | -10.27% | 0.92% | 28/139 | 51.69% | 正海生物 | 92.83% | 行业排名> |
| 2018-06-30 | 48.52% | -10.96% | 8.53% | 31/139 | 51.82% | 正海生物 | 92.44% | 行业排名> |
| 2018-03-31 | 44.71% | -18.23% | -18.93% | 28/139 | 51.21% | 正海生物 | 92.7% | 行业排名> |
| 2017-12-31 | 55.15% | -0.05% | 1.06% | 55/139 | 55.55% | 正海生物 | 93.67% | 行业排名> |
| 2017-09-30 | 54.57% | -2.11% | 0.14% | 22/139 | 52.9% | 正海生物 | 94.14% | 行业排名> |
| 2017-06-30 | 54.49% | -2.39% | -0.33% | 30/139 | 54.31% | 正海生物 | 93.83% | 行业排名> |
| 2017-03-31 | 54.68% | -3.98% | -0.91% | 22/139 | 53.53% | 正海生物 | 93.69% | 行业排名> |
| 2016-12-31 | 55.18% | -4.49% | -1.02% | 41/139 | 56.68% | 正海生物 | 92.79% | 行业排名> |
| 2016-09-30 | 55.74% | -3.18% | -0.15% | 16/139 | 51.06% | 健帆生物 | 84.23% | 行业排名> |
| 2016-06-30 | 55.83% | 3.56% | -1.96% | 22/139 | 51.97% | *ST明德 | 86.71% | 行业排名> |
| 2016-03-31 | 56.94% | 14.23% | -1.43% | 13/139 | 49.02% | 健帆生物 | 83.86% | 行业排名> |